Pro Share Advisors LLC Summit Therapeutics Inc. Transaction History

Pro Share Advisors LLC

  • $42.9 Billion
  • Q1 2025

A detailed history of Pro Share Advisors LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 53,187 shares of SMMT stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,187
Previous 60,830 12.56%
Holding current value
$1.48 Million
Previous $1.09 Million 5.53%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025
SELL
$16.65 - $23.76 $127,255 - $181,597
-7,643 Reduced 12.56%
53,187 $1.03 Million
Q4 2024

Feb 13, 2025
BUY
$17.52 - $23.46 $25,824 - $34,580
1,474 Added 2.48%
60,830 $1.09 Million
Q3 2024

Nov 13, 2024
BUY
$6.89 - $31.93 $3,438 - $15,933
499 Added 0.85%
59,356 $1.3 Million
Q2 2024

Aug 13, 2024
SELL
$2.39 - $10.92 $26,619 - $121,626
-11,138 Reduced 15.91%
58,857 $459,000
Q1 2024

May 08, 2024
BUY
$2.55 - $5.07 $15,389 - $30,597
6,035 Added 9.44%
69,995 $289,000
Q4 2023

Feb 14, 2024
BUY
$1.67 - $2.83 $5,502 - $9,324
3,295 Added 5.43%
63,960 $166,000
Q3 2023

Nov 13, 2023
BUY
$1.54 - $2.42 $694 - $1,091
451 Added 0.75%
60,665 $113,000
Q2 2023

Aug 10, 2023
BUY
$1.32 - $2.81 $15,634 - $33,281
11,844 Added 24.49%
60,214 $151,000
Q1 2023

May 11, 2023
BUY
$1.38 - $5.41 $43,772 - $171,599
31,719 Added 190.49%
48,370 $84,000
Q4 2022

Feb 02, 2023
SELL
$0.68 - $5.31 $186 - $1,454
-274 Reduced 1.62%
16,651 $70,000
Q3 2022

Nov 04, 2022
BUY
$0.89 - $1.63 $15,063 - $27,587
16,925 New
16,925 $20,000
Q2 2022

Aug 01, 2022
SELL
$0.92 - $2.38 $13,849 - $35,828
-15,054 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$2.0 - $3.45 $8,928 - $15,400
-4,464 Reduced 22.87%
15,054 $37,000
Q4 2021

Feb 08, 2022
SELL
$2.45 - $5.64 $11,424 - $26,299
-4,663 Reduced 19.28%
19,518 $52,000
Q3 2021

Nov 12, 2021
BUY
$4.83 - $8.27 $4,235 - $7,252
877 Added 3.76%
24,181 $121,000
Q2 2021

Aug 13, 2021
BUY
$5.15 - $8.46 $61,176 - $100,496
11,879 Added 103.97%
23,304 $174,000
Q1 2021

May 14, 2021
SELL
$5.17 - $11.19 $6,571 - $14,222
-1,271 Reduced 10.01%
11,425 $67,000
Q4 2020

Feb 09, 2021
BUY
$3.25 - $6.0 $41,262 - $76,176
12,696 New
12,696 $60,000

Others Institutions Holding SMMT

# of Institutions
238
Shares Held
87.3M
Call Options Held
1.77M
Put Options Held
2.48M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $5.61B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email